Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

OTC Awards

Apex and Lumentium bring a new experience to the UK event market

Specialist pharma conference and event management company Apex has signed an exclusive deal to become the sole representative of Lumentium in the UK.

Apex Events and Exhibitions

The inescapable rise of patient-centricity

The April issue of PME questions the meaning of ‘patient-centricity’ and whether we are achieving it.Patient-centricity has become a ubiquitous value within the pharmaceutical industry; however, is pharma delivering on...

Lucid Group Communications Limited

- PMLiVE

European approval for Skyrizi, hot on the heels of US

Welcome news, but can't replace $20bn Humira

- PMLiVE

Gilead gets ‘gold’ in England’s hepatitis C eradication drive

NHS England's tender process drives down cost of medicines

- PMLiVE

Brexit clock ticking once again, UK heads for European elections

New deadline gives pharma more time, but no more clarity

Great Expectations

The three things to think about in expected utility theory*

Bayer symbol

Bayer gains FDA priority review for prostate cancer drug

Could compete against J&J’s Erleada and Pfizer/Astellas’ Xtandi

- PMLiVE

OPEN Health Medical Communications announces Group MD promotions and welcomes new Creative Director

OPEN Health Medical Communications has announced the promotion of two members of its senior leadership team. Jen van Zwieten and Margot Hannah become Group Managing Directors, with responsibility to oversee...

OPEN Health

Roche Basel Switzerland

Roche to present new data on Spinraza rival

As Novartis stumbles, Roche pushing first oral SMA treatment

- PMLiVE

UK to add addiction warnings to opioids as use soars

Codeine-related deaths doubled in a decade

- PMLiVE

Lynparza could soon add first line ovarian use in Europe

Also first PARP inhibitor launched in China

It’s Complicated

Commercial executives should be more like their scientist colleagues

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links